D. Western Therapeutics Institute (TSE:4576) Total Equity: 円1,435.45 Mil (As of Dec. 2025)


TSE:4576 D. Western Therapeutics Institute Inc TSE:4576
45 GF Score
Price 円79.00
GF Value 円64.06
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is D. Western Therapeutics Institute Total Equity?

D. Western Therapeutics Institute TSE:4576 +3.95% 45 Total Equity is 円1,435.45 Mil as of Dec. 2025. GuruFocus rates TSE:4576 with a GF Score™ of 45/100 and a GF Value™ of 円64.06 (Modestly Overvalued). The stock has 3 warning signs investors should review.

D. Western Therapeutics Institute's total equity for the quarter that ended in Dec. 2025 was 円1,435.45 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

D. Western Therapeutics Institute Total Equity Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute Total Equity Chart

D. Western Therapeutics Institute Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,035.14 1,873.48 1,279.77 733.87 1,435.45

D. Western Therapeutics Institute Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 733.87 1,001.29 884.57 1,435.45 1,314.23
TSE:4576
45GF Score
D. Western Therapeutics Institute Inc TSE:4576
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D. Western Therapeutics Institute Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

D. Western Therapeutics Institute's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2169.461-734.012
=1,435.45

D. Western Therapeutics Institute's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2169.461-734.012
=1,435.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of 円1,435.45 Mil mean?
D. Western Therapeutics Institute (TSE:4576) has a Total Equity of 円1,435.45 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for D. Western Therapeutics Institute and its competitors.
Is D. Western Therapeutics Institute's Total Equity too high?
D. Western Therapeutics Institute's current Total Equity is 円1,435.45 Mil. Overall, D. Western Therapeutics Institute has a GF Score™ of 45/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does D. Western Therapeutics Institute's Total Equity compare to VRTX and REGN?
D. Western Therapeutics Institute's Total Equity of 円1,435.45 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current Total Equity is 円1,435.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D. Western Therapeutics Institute stock overvalued right now?
Based on GuruFocus' analysis, D. Western Therapeutics Institute (TSE:4576) is currently considered Modestly Overvalued. The stock's GF Value™ is 円64.06, compared to a current price of 円79.00 — trading 23.3% above its estimated fair value. The current Total Equity is 円1,435.45 Mil. D. Western Therapeutics Institute's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For D. Western Therapeutics Institute (TSE:4576), the current Total Equity is 円1,435.45 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of 円79.00 is trading 23.3% above its estimated GF Value™ of 円64.06. GuruFocus considers D. Western Therapeutics Institute to be Modestly Overvalued.

Key valuation signals for TSE:4576:

  • Total Equity: 円1,435.45 Mil
  • GF Value™: 円64.06 vs. price of 円79.00 (23.3% above fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

D. Western Therapeutics Institute Business Description

Other Exchanges 6DW:Germany
Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
45GF Score

Get the complete analysis for TSE:4576

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円79.00
Price
円64.06
GF Value